We are thrilled to announce that HarmonyCares has secured $200M in funding to bring its in-home value-based primary care model to more people across the U.S. HarmonyCares is already impacting the lives of over 75,000 patients across 15 states. We are so proud of this team and their mission. https://lnkd.in/gFpKn43j #ValueBasedCare #PrimaryCare
About us
Valtruis invests in, builds, and partners with companies that challenge the healthcare industry’s status quo and revolutionize the way care is accessed, delivered, experienced, and paid for. Founded on a commitment to accelerate meaningful change, Valtruis brings the functional expertise, access to capital and an expansive network that advance our partners’ evolution from early-stage development to industry-leading enterprises. Together, Valtruis and its partner companies will break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality and radically improve the patient experience.
- Website
-
http://valtruis.com
External link for Valtruis
- Industry
- Investment Management
- Company size
- 2-10 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Get directions
Chicago, IL, US
-
Get directions
New York, NY 10022, US
-
Get directions
Nashville, TN, US
Employees at Valtruis
Updates
-
Big news from Valtruis Portfolio Company Atropos Health! We are excited to see the value created from this partnership
New partnership announcement: Atropos Health has partnered with Norstella to expand the Atropos Evidence™ Network and Structured Clinical Trial Intelligence. This collaboration brings together cutting-edge AI technologies with global data to accelerate innovation for life science. With Norstella's extensive reach and Atropos Health's innovative Generative AI platform, GENEVA OS™, healthcare and life science leaders will have access to advanced evidence-generation tools that will enhance access to democratized federated healthcare data and speed to evidence generation and rapid insights. The combined expertise and solution offerings in real-world evidence between Atropos Health and Norstella are paving the way for faster, more efficient clinical research design, feasibility, and recruitment. Atropos Health will leverage Norstella's extensive reach, including companies such as Panalgo, Citeline, Evaluate, MMIT, and The Dedham Group to improve the quality, accuracy, and efficiency of evidence for their customers and accelerate the pathway to increased adoption of the practice of evidence-based medicine. Thanks to Mike Gallup, Kevin McCurry, Alice Jeffers, Dr. Brigham Hyde, and Kris Karson for bringing our teams together. Read more here: https://hubs.li/Q02C2p7y0 #HealthcareInnovation #EvidenceGeneration #ClinicalTrials #AtroposHealth #Norstella #GENEVAOS #AI #LifeSciences #RWE #Realworldevidence
Atropos Health Partners with Norstella to Expand Structured Clinical Trial Intelligence — Atropos Health
atroposhealth.com
-
Last week we hosted another fabulous women’s gathering alongside Mia Jung of Welsh, Carson, Anderson & Stowe at our Valtruis Nashville office. A huge thank you to everyone who attended! We are excited to continue fostering and strengthening communities for women in healthcare. Stay tuned for future women’s events! #womeninhealthcare #womenexecutives #nashville
-
-
As we approach the third anniversary of Valtruis' founding, we are thrilled to announce our Series B investment in Atropos Health. This partnership highlights our continued expansion into software-focused healthcare innovation while maintaining our commitment to challenging the status quo and setting a new, higher standard for efficient, high-quality, coordinated healthcare. We welcome Atropos to the Valtruis family and look forward to all that we will achieve together. #AtroposHealth #RealWorldData #GenerativeAI https://lnkd.in/gJ3vS36F
Atropos Health Raises $33M to Scale the Automation of High-Quality, Personalized Real-World Evidence Leveraging Generative AI
businesswire.com
-
More exciting news from the Valtruis Portfolio: Wayspring announced their latest capital raise, led by CVS Health Ventures! Justin Brock, Executive Director and Partner at CVS Health Ventures, highlighted the strategic nature of the investment, saying, “Wayspring has demonstrated an exceptional ability to execute a complex care model that profoundly impacts the lives of those with substance use disorder.” This strategic partnership highlights the promising proof points and impact of Wayspring’s approach to transforming the behavioral health landscape. #Wayspring #sud #behavioralhealth https://lnkd.in/epRVAKiE
Wayspring Secures Minority Investment Led by CVS Health Ventures - Wayspring
https://wayspring.com
-
We are delighted to announce our funding of Tuesday Health! We created and launched Tuesday Health to fulfill our vision for end-of-life care where patients, families, and caregivers are fully supported. We are proud of the work this team has accomplished and look forward to the impact they'll bring to Ohio. We were joined in the $60m strategic round by The Blue Venture Fund, Mass General Brigham Ventures, and CareSource. #TuesdayHealth #endoflife #valuebasedcare https://lnkd.in/detkJsS2
Tuesday Health Launch
https://www.tuesdayhealth.com
-
Valtruis Managing Director Anna Haghgooie joined WittKieffer's Converge Cast to talk about her true North Star in healthcare – to marry care efficiency and cost-effectiveness with human-to-human engagement. Tune in using the link below or on Spotify, Apple Podcasts, and PodBean.
Our latest episode of WittKieffer’s Converge Cast focuses on the transformative potential of value-based care. Valtruis' Anna Haghgooie shares her insight on investment in and innovation around “true” value-based care which provides holistic and viable models of integrated care for patients and populations. Haghgooie's North Star in healthcare is to marry care efficiency and cost-effectiveness with human-to-human engagement. Enjoy her inspirational conversation with Shelly Carolan and Michael Castleman. WittKieffer's Converge Cast series is dedicated to exploring important, meaningful ideas that bring people and organizations together across the Quality of Life Ecosystem – which spans the broader life sciences, healthcare, and education sectors. We aim to make the world better by fostering fresh insights into today's most fundamental issues and challenges. #convergecast #impactfulleadership
WittKieffer Converge Cast Episode 3 | Anna Haghgooie: Investing in Innovation Around True Value-Based Care
wittkieffer.com
-
Late last week, the Healthcare Leadership Council (HLC) released “Achieving the Promise of Patient-Centered Value-Based Care,” a joint report from Wellvana, a Valtruis-funded company, and AdventHealth. The report highlights specific steps to accelerate the transition from traditional healthcare fee-for-service payment models to models prioritizing value, prevention, and wellness. A round of applause for Wellvana on their continued dedication to driving the advancement of value-based care. We are proud to support your mission and vision for the future of healthcare. Find the press release and access the full report here: https://lnkd.in/g6FbBHpH
Recommendations to Advance Value-Based Care
wellvana.com
-
Feeling energized after our gathering of Chicago women healthcare leaders at the Valtruis Chicago Office yesterday. Thank you to all who joined us and contributed to the vibrant exchange of ideas and connections. Let's keep pushing boundaries and driving positive change in healthcare together! Special shoutout to our co-host, Mia Jung of WCAS. We are always grateful for your support and collaboration. #WomenInHealthcare #Chicago
-
-
We are thrilled to continue to support InStride Health’s mission to transform the lives of children, teens, and young adults with anxiety and OCD. Congratulations to this incredible team. Read the full press release here: https://bit.ly/49bGNC6 #behavioralhealth #instridehealth #seriesb
Today we announced the closing of an oversubscribed $30 million Series B funding round, led by General Catalyst with participation from previous investors .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab, bringing our total capital raised to date to $56 million. Driven by our commitment to providing uncompromising clinical care, InStride Health delivers best-in-class, insurance-based, specialty treatment throughout the Northeast for children with anxiety and OCD. This new capital enables InStride Health to continue our investment in clinical quality and reach significantly more children and their families. We are incredibly proud of the clinical model we've built, the exceptional care our teams deliver, and the excellent outcomes and high satisfaction levels our patients and their families report. Thank you to the InStride Health families, program graduates, advocates, referring providers, insurers, investors, and passionate employees for your continued support in delivering on our mission. Read the press release here https://bit.ly/49bGNC6 #behavioralhealth #funding #mentalhealthmatters #healthinnovation #seriesB #innovation #instridehealth #pressrelease
-